September 26th, 2013
For more information on this event, contact: Eric Rude (erude@health.nyc.gov)
Last Updated on January 25, 2020 by HepFree NYC
On October 16, 2014, the fee-for-service (FFS) pharmacy program implemented clinical criteria for Hepatitis C Virus (HCV) drug therapy, as was recommended by the Drug Utilization Review Board (DURB) at the September 18, 2014 meeting. Included in this criteria were the following ...
Fieldwork East Inc. is an independent national multi-office market research facility, specializing in medical research for new product development. Doctors, Nurses, Hospital Administrators and other professional individuals involved in a multitude of medical areas are invited to ...
Position will be responsible for leading projects to advance local health department program efforts to adapt their HIV, STI, and hepatitis programs to changes in the public health and healthcare systems resulting from the implementation of the ACA.
HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010.Ann Drobnik, MPH, Jessie Pinchoff, PhD Candidate, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Jay K. Varma, MD, Sarah L. Braunstein, PhD. Division of ...
December 2012 NYC Hepatitis ABC Newsletter – Click here to view online! http://eepurl.com/sONsn
Training Notes…. Document Attachments: Hospital Financial Assistance (Hannah Weinstein) HCC Options (Yvonne Cummings) CBWCHC (Calvin Yu) HepCAP (Paulina Vargas) HepCAP Flyer Federal Poverty Level Info Medicaid Buy In Program (Carol Santangelo) Hepatitis Med Coverage (Adrian...
This RFA will support 3 innovative HCV care and treatment models that will address the needs and the barriers PWID with HCV face when accessing HCV services in traditional health care settings.
Organizations wishing to receive City Council funding in FY 2019 must complete Discretionary Funding application by February 20, 2018.
